Image by Freepik
A new Yale School of Medicine and Icahn School of Medicine at Mount Sinai study found that people who have experienced brain fog, confusion, pain, and extreme fatigue for months or longer after being infected with COVID-19 have different immune and hormonal responses to the virus.
These different responses may help scientists pinpoint the origins and maybe solutions for the frequently debilitating condition that has impacted millions worldwide. The U.S. estimates 7.5% of SARS-CoV-2 infections develop long-term COVID.
“If you are a doctor doing routine lab work on these patients, you are not going to find these signals,” said Akiko Iwasaki, Sterling Professor of Immunobiology at Yale and co-senior author of the paper.
The findings appeared in Nature on Sept. 25.
The study examined blood samples from 268 persons who had long-term COVID symptoms for an average of one year, had recovered from COVID-19, or had no past infections. The researchers found substantial changes in circulating antibodies and other immune system cells between long-COVID patients and others.
Long-term COVID patients have higher levels of antibodies that combat non-COVID-19 viruses, including Epstein-Barr virus, a human herpesvirus related to many malignancies. These individuals also had significantly reduced cortisol levels, a stress hormone secreted by the adrenal glands.
The scientists say these data indicate fundamental molecular processes related with chronic COVID, but the variety of individual reactions makes creating treatments difficult.
“There is no ‘silver bullet’ for treating long COVID, because it is an illness that infiltrates complex systems such as the immune and hormonal regulation,” said co-senior author David Putrino, a professor of rehabilitation and human performance at Icahn Mount Sinai and director of the Cohen Center for Recovery From Complex Chronic Illness
Iwasaki said the new findings may contribute in the development of novel diagnostics and treatments.
“Once we have more information on these signals, we can start to think about designing the right trials to treat this condition,” she said.
more recommended stories
Skin Cancer Risk After Transplant Needs Better ScreeningKey Points Summary Solid organ transplant.
Polygenic Risk Scores Improve Early Heart Disease DetectionKey Points A new multicondition polygenic.
Prenatal Sedatives Psychiatric Risk: New Study FindingsQuick Summary A large South Korean.
Cardiovascular Health from Early Life Lowers Disease RiskKey Points Summary: Cumulative cardiovascular health.
Early Autism Detection Using Wearable Sensors in InfantsKey Highlights: Wearable movement sensors may.
Alzheimer’s Disease Driven by Cancer Gene MutationsKey Highlights Microglial cells in Alzheimer’s.
Cardiovascular Risk Rises with Heatwaves Over 38°CKey Highlights Extreme heat (>38°C) significantly.
Psychedelic Use Linked to Major Life Changes StudyQuick Summary 83% of users reported.
Brain Categorization Redefined by New Neuroscience StudyKey Highlights Brain Categorization is not.
One Health Summit: WHO Leads Global Health ResponseKey Highlights Global leaders convened in.
Leave a Comment